DK1126846T3 - Anvendelse af en nikotinreceptoragonist til behandling af tvangsneuroser i form af obsessiv kompulsiv tilstand - Google Patents
Anvendelse af en nikotinreceptoragonist til behandling af tvangsneuroser i form af obsessiv kompulsiv tilstandInfo
- Publication number
- DK1126846T3 DK1126846T3 DK99957446T DK99957446T DK1126846T3 DK 1126846 T3 DK1126846 T3 DK 1126846T3 DK 99957446 T DK99957446 T DK 99957446T DK 99957446 T DK99957446 T DK 99957446T DK 1126846 T3 DK1126846 T3 DK 1126846T3
- Authority
- DK
- Denmark
- Prior art keywords
- obsessive compulsive
- treatment
- receptor agonist
- nicotine receptor
- compulsive disorder
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 3
- 229960002715 nicotine Drugs 0.000 title abstract 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000018 receptor agonist Substances 0.000 title abstract 3
- 229940044601 receptor agonist Drugs 0.000 title abstract 3
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803732A SE9803732D0 (sv) | 1998-11-02 | 1998-11-02 | Nicotine treatment for obsessive compulsive disorder |
| PCT/SE1999/001948 WO2000025783A1 (en) | 1998-11-02 | 1999-10-29 | Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1126846T3 true DK1126846T3 (da) | 2003-09-29 |
Family
ID=20413142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99957446T DK1126846T3 (da) | 1998-11-02 | 1999-10-29 | Anvendelse af en nikotinreceptoragonist til behandling af tvangsneuroser i form af obsessiv kompulsiv tilstand |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1126846B1 (da) |
| JP (1) | JP2002528501A (da) |
| AT (1) | ATE246503T1 (da) |
| AU (1) | AU1514700A (da) |
| CA (1) | CA2347855A1 (da) |
| DE (1) | DE69910242T2 (da) |
| DK (1) | DK1126846T3 (da) |
| ES (1) | ES2203210T3 (da) |
| NZ (1) | NZ511226A (da) |
| PT (1) | PT1126846E (da) |
| SE (1) | SE9803732D0 (da) |
| WO (1) | WO2000025783A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| CN100398103C (zh) | 2000-10-13 | 2008-07-02 | 神经研究公司 | 通过烟碱性受体激动剂和单胺能物质的联合作用治疗情感性精神障碍 |
| DE20018196U1 (de) | 2000-10-25 | 2001-01-11 | Peter, Michael N., 22297 Hamburg | Erzeugnis aus Zuckerware für Raucherentwöhnung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776956A (en) * | 1996-07-30 | 1998-07-07 | Lectec Corporation | Use of cotinine in treating psychiatric disorders |
-
1998
- 1998-11-02 SE SE9803732A patent/SE9803732D0/xx unknown
-
1999
- 1999-10-29 WO PCT/SE1999/001948 patent/WO2000025783A1/en not_active Ceased
- 1999-10-29 DK DK99957446T patent/DK1126846T3/da active
- 1999-10-29 AU AU15147/00A patent/AU1514700A/en not_active Abandoned
- 1999-10-29 NZ NZ511226A patent/NZ511226A/xx unknown
- 1999-10-29 PT PT99957446T patent/PT1126846E/pt unknown
- 1999-10-29 AT AT99957446T patent/ATE246503T1/de not_active IP Right Cessation
- 1999-10-29 EP EP99957446A patent/EP1126846B1/en not_active Expired - Lifetime
- 1999-10-29 JP JP2000579224A patent/JP2002528501A/ja not_active Withdrawn
- 1999-10-29 DE DE69910242T patent/DE69910242T2/de not_active Expired - Fee Related
- 1999-10-29 CA CA002347855A patent/CA2347855A1/en not_active Abandoned
- 1999-10-29 ES ES99957446T patent/ES2203210T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2203210T3 (es) | 2004-04-01 |
| SE9803732D0 (sv) | 1998-11-02 |
| DE69910242T2 (de) | 2004-06-17 |
| EP1126846A1 (en) | 2001-08-29 |
| EP1126846B1 (en) | 2003-08-06 |
| AU1514700A (en) | 2000-05-22 |
| ATE246503T1 (de) | 2003-08-15 |
| JP2002528501A (ja) | 2002-09-03 |
| WO2000025783A1 (en) | 2000-05-11 |
| CA2347855A1 (en) | 2000-05-11 |
| NZ511226A (en) | 2003-01-31 |
| DE69910242D1 (de) | 2003-09-11 |
| PT1126846E (pt) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0867178T3 (da) | Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser | |
| AU4818000A (en) | Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands | |
| WO2001001973A8 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| BR0210855A (pt) | Método de fabricação de formulações de liberação prolongada | |
| WO2001087328A3 (en) | Interleukin-1 inhibitors in the treatment of diseases | |
| BR0206568A (pt) | Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição | |
| NO20015413D0 (no) | Anvendelse av dopamin-D3-reseptor-ligander for fremstilling av medikamenter for behandling av nyrefunksjonsforstyrrelser | |
| EE200200107A (et) | Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks | |
| NO20013414L (no) | Ny anvendelse av melagatran | |
| DK0966285T3 (da) | Anvendelse af (+)mefloquin til behandling af malaria | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
| DK1126846T3 (da) | Anvendelse af en nikotinreceptoragonist til behandling af tvangsneuroser i form af obsessiv kompulsiv tilstand | |
| DE69917005D1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| SE9902597D0 (sv) | New use | |
| SE9904424D0 (sv) | Use of interleukin-6 in combination with leptin in treatment of obesity | |
| NO20005131L (no) | Nye behandlinger for nervøse forstyrrelser | |
| WO1999051216A3 (en) | 3-pyridyloxyalkylamine or aryloxyalkylamine derivatives as cholinergic agonists | |
| TR200100670T2 (tr) | R(+)-alfa-(2,3-Dimetoksifenil)-1- [2-(4-florofenil)etil]-4-piperidinmetanol' ün uyku düzensizlikleri tedavisinde kullanımı. | |
| EE200100193A (et) | 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises | |
| SE0102888D0 (sv) | New formulation | |
| WO2005049024A3 (de) | Feste pharmazeutische zubereitungsform | |
| MX2008000780A (es) | Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica. | |
| AU5691199A (en) | Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands | |
| WO2004034967A3 (en) | 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety |